TY - JOUR
T1 - Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC)
T2 - Supporting the transition from strategy to action [version 1; referees: 2 approved, 1 approved with reservations]
AU - Peacock, Sharon
AU - Fukuda, Keiji
AU - Limmathurotsakul, Direk
AU - Okeke, Iruka N.
AU - Shetty, Nandini
AU - van Doorn, Rogier
AU - Feasey, Nicholas A.
AU - Chiara, Francesca
AU - Zoubiane, Ghada
AU - Jinks, Tim
AU - Parkhill, Julian
AU - Patel, Jean
AU - Reid, Stuart W.J.
AU - Holmes, Alison H.
N1 - Publisher Copyright:
© 2018 Fukuda K et al.
PY - 2018
Y1 - 2018
N2 - In recognition of the central importance of surveillance and epidemiology in the control of antimicrobial resistance and the need to strengthen surveillance at all levels, Wellcome has brought together a new international expert group SEDRIC (Surveillance and Epidemiology of Drug Resistant Infections Consortium). SEDRIC aims to advance and transform the ways of tracking, sharing and analysing rates of infection and drug resistance, burden of disease, information on antibiotic use, opportunities for preventative measures such as vaccines, and contamination of the environment. SEDRIC will strengthen the availability of information needed to monitor and track risks, including an evaluation of access to, and utility of data generated by pharma and research activities, and will support the translation of surveillance data into interventions, changes in policy and more effective practices. Ways of working will include the provision of independent scientific analysis, advocacy and expert advice to groups, such as the Wellcome Drug Resistant Infection Priority Programme. A priority for SEDRIC's first Working Group is to review mechanisms to strengthen the generation, collection, collation and dissemination of high quality data, together with the need for creativity in the use of existing data and proxy measures, and linking to existing in-country networking infrastructure. SEDRIC will also promote the translation of technological innovations into public health solutions.
AB - In recognition of the central importance of surveillance and epidemiology in the control of antimicrobial resistance and the need to strengthen surveillance at all levels, Wellcome has brought together a new international expert group SEDRIC (Surveillance and Epidemiology of Drug Resistant Infections Consortium). SEDRIC aims to advance and transform the ways of tracking, sharing and analysing rates of infection and drug resistance, burden of disease, information on antibiotic use, opportunities for preventative measures such as vaccines, and contamination of the environment. SEDRIC will strengthen the availability of information needed to monitor and track risks, including an evaluation of access to, and utility of data generated by pharma and research activities, and will support the translation of surveillance data into interventions, changes in policy and more effective practices. Ways of working will include the provision of independent scientific analysis, advocacy and expert advice to groups, such as the Wellcome Drug Resistant Infection Priority Programme. A priority for SEDRIC's first Working Group is to review mechanisms to strengthen the generation, collection, collation and dissemination of high quality data, together with the need for creativity in the use of existing data and proxy measures, and linking to existing in-country networking infrastructure. SEDRIC will also promote the translation of technological innovations into public health solutions.
KW - Antimicrobial
KW - Drug resistant infections
KW - Epidemiology
KW - SEDRIC
KW - Surveillance
UR - http://www.scopus.com/inward/record.url?scp=85048270103&partnerID=8YFLogxK
U2 - 10.12688/wellcomeopenres.14586.1
DO - 10.12688/wellcomeopenres.14586.1
M3 - Letter
AN - SCOPUS:85048270103
SN - 2398-502X
VL - 3
JO - Wellcome Open Research
JF - Wellcome Open Research
M1 - 59
ER -